Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers
Year: 2022
Type: article
Study design: Observational Study
Source: Gynecologic Oncology
Authors: Sarah Ehmann, Dib Sassine, Alli M. Straubhar, Aaron M. Praiss, Carol Aghajanian, Kaled M. Alektiar, Vance Broach, Karen A. Cadoo, Elizabeth L. Jewell, Amir Momeni Boroujeni, Chrisann Kyi, Mario M. Leitao, Jennifer J. Mueller, Rajmohan Murali, Shirin Issa Bhaloo, Roisin E. O'Cearbhaill, Kay J. Park, Yukio Sonoda, Britta Weigelt, Dmitriy Zamarin, Nadeem Abu-Rustum, Claire F. Friedman
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Conquer Cancer Foundation, Breast Cancer Research Foundation, Bristol-Myers Squibb, Pfizer, AstraZeneca, Regeneron Pharmaceuticals, Intuitive Surgical, Celldex Therapeutics, Mersana Therapeutics, Cycle for Survival, Moderna, Seagen, Irish Cancer Society, Eisai, Astellas Pharma, Plexxikon, National Institutes of Health, Genentech, National Cancer Institute
OpenAlex ID: W4306318770